Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HPV, Human Papillomavirus Viruses, Human Papilloma Virus Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04425291
What this trial is testing

Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Who this might be right for
Cervical CancerVulvar CancerVaginal Cancer+11 more
Shanghai Bovax Biotechnology Co., Ltd. 1,680
Not applicableStudy completedNCT05736718
What this trial is testing

Engaging Clinical Champions to Improve HPV Vaccination

Who this might be right for
Human Papilloma Virus
UNC Lineberger Comprehensive Cancer Center 47
Large-scale testing (Phase 3)Study completedNCT03525210
What this trial is testing

Study of Safety, Tolerability and Immunogenicity of Gardasil®9 in Immunocompromised Patients

Who this might be right for
Human Papilloma VirusHivOrgan Transplants
Universitaire Ziekenhuizen KU Leuven 271
Not applicableLooking for participantsNCT06831383
What this trial is testing

The STOP-HPV Scale Up Study

Who this might be right for
Human Papilloma Virus Vaccine
University of California, Los Angeles 100,000
Large-scale testing (Phase 3)Active Not RecruitingNCT06041061
What this trial is testing

Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years

Who this might be right for
HPV InfectioNHPV-Related Carcinoma
Sinocelltech Ltd. 18,000
Not applicableStudy completedNCT03442062
What this trial is testing

Quality Improvement Strategies to Increase Human Papillomavirus (HPV) Vaccination

Who this might be right for
Human Papillomavirus Infection
University of North Carolina, Chapel Hill 264
Large-scale testing (Phase 3)UnknownNCT03296397
What this trial is testing

Efficacy of Quadrivalent HPV Vaccine to Prevent Relapses of Genital Warts After Initial Therapeutic Response

Who this might be right for
Genital Warts
Assistance Publique - Hôpitaux de Paris 300
Early research (Phase 1)Study completedNCT04083196
What this trial is testing

A Randomized, Blinded, Placebo-controlled Phase I Clinical Trial Evaluating the Safety and Preliminary Immunogenicity of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years

Who this might be right for
HPV InfectionHPV-Related Cervical Carcinoma
National Vaccine and Serum Institute, China 90
Large-scale testing (Phase 3)Study completedNCT00423046
What this trial is testing

Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 1,106
Large-scale testing (Phase 3)Study completedNCT00799825
What this trial is testing

Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 346
Not applicableStudy completedNCT07200414
What this trial is testing

Strengthening HPV Vaccination and Adolescent Health Research Program in Nigeria (SHARP)

Who this might be right for
Human Papillomavirus (HPV) VaccineHuman Papillomavirus (HPV) VaccinesHuman Papillomavirus (HPV) Infections+1 more
Johns Hopkins Bloomberg School of Public Health 12,654
Large-scale testing (Phase 3)Study completedNCT00294047
What this trial is testing

Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 5,752
Testing effectiveness (Phase 2)Study completedNCT00710593
What this trial is testing

Impact of a Human Papilloma Virus (HPV) Vaccine in HIV-Infected Young Women

Who this might be right for
HIV Infection
University of North Carolina, Chapel Hill 99
Testing effectiveness (Phase 2)Study completedNCT05087849
What this trial is testing

Intralesional HPV Vaccine for Condylomata

Who this might be right for
Human Papilloma VirusWartsWarts, Genital+2 more
University of California, San Francisco 2
Not applicableStudy completedNCT01030562
What this trial is testing

Immunogenicity of Off-Schedule Dosing of HPV Vaccine

Who this might be right for
Papilloma Viral Infection
National Institute of Allergy and Infectious Diseases (NIAID) 1,321
Testing effectiveness (Phase 2)Study completedNCT00365378
What this trial is testing

Study of Human Papillomavirus (HPV) 16 Vaccine in the Prevention of HPV 16 Infection in 16- to 23-Year-Old Females (V501-005)

Who this might be right for
HPV 16 Infection
Merck Sharp & Dohme LLC 2,409
Early research (Phase 1)Study completedNCT00667563
What this trial is testing

Vaccine Therapy in Preventing HPV in HIV-Positive Women in India

Who this might be right for
Cervical CancerNonneoplastic ConditionPrecancerous Condition
AIDS Malignancy Consortium 150
Not applicableStudy completedNCT00828555
What this trial is testing

Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting

Who this might be right for
Influenza VaccinePapillomavirus InfectionPertussis
Duke University 3,988
Large-scale testing (Phase 3)Not Yet RecruitingNCT07824310
What this trial is testing

Immunogenicity and Safety of HPV-4 Vaccine With or Without Td Vaccine in Children

Who this might be right for
Human Papillomavirus (HPV) Infection
PT Bio Farma 266
Testing effectiveness (Phase 2)Study completedNCT00546078
What this trial is testing

Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 116
Next Page